Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zhang M et al. | [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. | 2003 | Zhonghua Yi Xue Za Zhi | pmid:12921638 |
Honda K et al. | Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. | 2003 | J. Exp. Med. | pmid:12925672 |
Mendez M and LaPointe MC | PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. | 2003 | Hypertension | pmid:12885795 |
Li L et al. | Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. | 2003 | Gastroenterology | pmid:12891549 |
Vosseler CA et al. | Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12859958 |
Aoun P et al. | Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. | 2003 | Eur. J. Pharmacol. | pmid:12860474 |
Zanoni G et al. | First total synthesis of JS isoprostane. | 2003 | J. Org. Chem. | pmid:12868940 |
Zahradka P et al. | Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation. | 2003 | Mol. Cell. Biochem. | pmid:12841350 |
Keelan JA et al. | Cytokines, prostaglandins and parturition--a review. | 2003 | Placenta | pmid:12842412 |
Chen CW et al. | Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. | 2003 | J. Immunol. | pmid:12847270 |
Date M et al. | 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. | 2003 | Liver Int. | pmid:14986820 |
Piliponsky AM et al. | Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. | 2003 | Blood | pmid:12393403 |
Yuan Z et al. | Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis. | 2003 | Cardiovasc. Res. | pmid:14499870 |
Lee TS et al. | Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. | 2003 | J. Biol. Chem. | pmid:12642589 |
Pavan L et al. | Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. | 2003 | Carcinogenesis | pmid:12807721 |
Guyton K et al. | Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. | 2003 | Shock | pmid:12813370 |
Burgermeister E et al. | Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. | 2003 | Oncogene | pmid:12813462 |
Satoh T et al. | Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress. | 2003 | Eur. J. Neurosci. | pmid:12814358 |
Ianaro A et al. | Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response. | 2003 | Mol. Pharmacol. | pmid:12815164 |
Zingarelli B et al. | Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. | 2003 | J. Immunol. | pmid:14662889 |
Urade Y et al. | Sleep regulation in adenosine A2A receptor-deficient mice. | 2003 | Neurology | pmid:14663019 |
Placha W et al. | The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. | 2003 | Melanoma Res. | pmid:14512786 |
Fukuchi K et al. | Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. | 2003 | J. Dent. Res. | pmid:14514760 |
Józkowicz A et al. | Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma. | 2003 | Acta Biochim. Pol. | pmid:14515149 |
Collin M and Thiemermann C | The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. | 2003 | Eur. J. Pharmacol. | pmid:12969773 |
Cuzzocrea S et al. | Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. | 2003 | Br. J. Pharmacol. | pmid:12970094 |
Farrow B et al. | Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. | 2003 | Surgery | pmid:12947319 |
Zhang M et al. | Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. | 2003 | J. Huazhong Univ. Sci. Technol. Med. Sci. | pmid:12973930 |
Niyonsaba F et al. | Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. | 2003 | Curr Drug Targets Inflamm Allergy | pmid:14561157 |
Powell WS | 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? | 2003 | J. Clin. Invest. | pmid:12975467 |
Chen YX et al. | 15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line. | 2003 | World J. Gastroenterol. | pmid:14562367 |
Bell-Parikh LC et al. | Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. | 2003 | J. Clin. Invest. | pmid:12975479 |
Shichijo M et al. | Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. | 2003 | J. Pharmacol. Exp. Ther. | pmid:12975488 |
Gilroy DW et al. | Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. | 2003 | FASEB J. | pmid:14563690 |
Pierzchalska M et al. | Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. | 2003 | J. Allergy Clin. Immunol. | pmid:12743569 |
Okano H et al. | 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma. | 2003 | Lab. Invest. | pmid:14563954 |
Gao L et al. | Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. | 2003 | J. Biol. Chem. | pmid:12746435 |
Kanbe E et al. | DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand. | 2003 | Exp. Hematol. | pmid:12691917 |
Jowsey IR et al. | Expression of the murine glutathione S-transferase alpha3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the pro-adipogenic eicosanoid 15-deoxy-Delta12,14-prostaglandin J2. | 2003 | Biochem. Biophys. Res. Commun. | pmid:14652005 |
Zernecke A et al. | Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. | 2003 | FASEB J. | pmid:12692090 |
Hammad H et al. | Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. | 2003 | J. Immunol. | pmid:14530310 |
Garg TK and Chang JY | Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. | 2003 | BMC Ophthalmol | pmid:12659653 |
Fukuda T | [Trend in chemical mediator research in asthma and its application for asthma treatment]. | 2003 | Nihon Kokyuki Gakkai Zasshi | pmid:14531291 |
Pérez-Sala D et al. | Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. | 2003 | J. Biol. Chem. | pmid:14532268 |
Chung YW et al. | [Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells]. | 2003 | Korean J Gastroenterol | pmid:14532729 |
Komar CM and Curry TE | Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. | 2003 | Biol. Reprod. | pmid:12700202 |
Worley JR et al. | Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. | 2003 | J. Biol. Chem. | pmid:14534304 |
Bernardo A et al. | 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms. | 2003 | J. Neurochem. | pmid:14535956 |
Ianaro A et al. | 2-Cyclopenten-1-one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaB. | 2003 | FEBS Lett. | pmid:14550540 |
Imaizumi T et al. | Effect of 15-deoxy-delta12,14-prostaglandin J2 on IL-1beta-induced expression of epithelial neutrophil-activating protein-78 in human endothelial cells. | 2003 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:14580366 |
Lu S et al. | Specific gene expression of isoforms in cyclooxygenase pathway to generate PGJ2 derivatives during the differentiation of 3T3-L1 adipocytes. | 2003 | Adv. Exp. Med. Biol. | pmid:12751756 |
Imaizumi T et al. | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. | 2003 | Int. Arch. Allergy Immunol. | pmid:12759491 |
Sommer A et al. | A dominant role for extracellular glutathione S-transferase from Onchocerca volvulus is the production of prostaglandin D2. | 2003 | Infect. Immun. | pmid:12761146 |
Irikura D et al. | Cloning, expression, crystallization, and preliminary X-ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. | 2003 | J. Biochem. | pmid:12761195 |
Shibata T et al. | Thioredoxin as a molecular target of cyclopentenone prostaglandins. | 2003 | J. Biol. Chem. | pmid:12709421 |
Zhuang H et al. | Regulation of heme oxygenase expression by cyclopentenone prostaglandins. | 2003 | Exp. Biol. Med. (Maywood) | pmid:12709576 |
Kämpfer H et al. | Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. | 2003 | J. Invest. Dermatol. | pmid:12713596 |
Brown JR et al. | Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). | 2003 | J. Leukoc. Biol. | pmid:12714573 |
Tautenhahn A et al. | Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis. | 2003 | J. Leukoc. Biol. | pmid:12714582 |
Desmond JC et al. | The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. | 2003 | Cancer Res. | pmid:12543809 |
Tanaka H et al. | Possible involvement of prostaglandins F(2alpha) and D(2) in acetylcholine-induced positive inotropy in isolated mouse left atria. | 2003 | Pharmacology | pmid:12571412 |
Söderström M et al. | Novel prostaglandin D(2)-derived activators of peroxisome proliferator-activated receptor-gamma are formed in macrophage cell cultures. | 2003 | Biochim. Biophys. Acta | pmid:12573447 |
Gibbons H et al. | Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells. | 2003 | Brain Res. Mol. Brain Res. | pmid:12573534 |
Patel HJ et al. | Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. | 2003 | J. Immunol. | pmid:12594295 |
Ruan XZ et al. | PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. | 2003 | J. Am. Soc. Nephrol. | pmid:12595494 |
Li L et al. | RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. | 2003 | J. Biol. Chem. | pmid:12493770 |
Winnett G et al. | Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. | 2003 | Int. J. Cancer | pmid:12494466 |
Kalla R et al. | Loss of microglial ramification in microglia-astrocyte cocultures: involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. | 2003 | Glia | pmid:12465045 |
Arici M et al. | Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. | 2003 | J. Am. Soc. Nephrol. | pmid:12506134 |
Badawi AF and Badr MZ | Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. | 2003 | Int. J. Cancer | pmid:12455057 |
Weber SM et al. | Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. | 2003 | Am. J. Physiol. Endocrinol. Metab. | pmid:12517740 |
Pang L et al. | Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. | 2003 | J. Immunol. | pmid:12517972 |
Hashimoto T et al. | Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs. | 2003 | J Ocul Pharmacol Ther | pmid:14733714 |
Zhang X et al. | Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin. | 2003 | BioTechniques | pmid:14682047 |
Kanaoka Y and Urade Y | Hematopoietic prostaglandin D synthase. | 2003 Aug-Sep | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12895599 |
Nagata K and Hirai H | The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. | 2003 Aug-Sep | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12895600 |
Powell WS | A novel PGD(2) receptor expressed in eosinophils. | 2003 Aug-Sep | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12895601 |
Kabashima K and Narumiya S | The DP receptor, allergic inflammation and asthma. | 2003 Aug-Sep | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12895602 |
Moore RM et al. | Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. | 2003 Feb-Mar | Placenta | pmid:12566244 |
Dong YG et al. | Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells. | 2004 | Acta Pharmacol. Sin. | pmid:14704122 |
Chen Q et al. | A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. | 2004 | Anal. Biochem. | pmid:15556564 |
Kim BE et al. | Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2. | 2004 | Exp. Mol. Med. | pmid:15557816 |
Józkowicz A et al. | 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15560113 |
Koda N et al. | Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. | 2004 | Arch. Biochem. Biophys. | pmid:15047184 |
Saydam O et al. | Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication. | 2004 | J. Virol. | pmid:15047795 |
Woolhiser MR et al. | Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. | 2004 | Clin. Immunol. | pmid:15003814 |
Relic B et al. | 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. | 2004 | J. Biol. Chem. | pmid:15004016 |
Tsuji T et al. | Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. | 2004 | Biol. Pharm. Bull. | pmid:15467193 |
Konopleva M et al. | Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. | 2004 | Mol. Cancer Ther. | pmid:15486192 |
Ishii T and Uchida K | Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. | 2004 | Chem. Res. Toxicol. | pmid:15487891 |
Li Z et al. | Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? | 2004 | J. Neurosci. Res. | pmid:15523637 |
Levonen AL et al. | Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. | 2004 | Biochem. J. | pmid:14616092 |
Ehara N et al. | Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15358182 |
Yuan ZY et al. | PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. | 2004 | Chin. Med. J. | pmid:15361304 |
Dugo L et al. | 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. | 2004 | Eur. J. Pharmacol. | pmid:15364008 |
Li L et al. | Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. | 2004 | J. Hepatol. | pmid:15336443 |
Zhao ML et al. | 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. | 2004 | J. Neuroimmunol. | pmid:15265671 |
Zhang X et al. | Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. | 2004 | Blood | pmid:15265789 |
Azuma Y et al. | Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. | 2004 | Pharmacology | pmid:15240994 |
Zhang C et al. | The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. | 2004 | J. Invest. Dermatol. | pmid:15245439 |